All GLG News Analyses Filed Under: Business of Medicine

Medicare has launched a pilot online personal health records program in South Carolina.  This programs provides thousands of Medicare beneficiaries access to personal health records (PHRs) containing their hospital and physician claims information.  Although information on their prescription...

Issue: Risk of fraud motivated contamination, and vendor quality failures, could and should have been seen long in advance, and nearly every drug and device faces this threat.  Outsourcing Managers have been entirely cost driven, without exercising adequate management of supply chain...

Physician ranking systems will certainly be a part of medical practice. But the real utility is not going to be in allowing patients to choose the "best" doctors--that will perpetuate the fallacy of drawing conclusions about a specific case from the general data. And the ability of this information...

Ranking doctors and hospitals will certainly move the most profitable patients able to afford commercial health insurance AND travel.  Medical Providers who help set their (local) standards to affect real outcomes reporting regular consumers can understand will increase their market share. ...

Wal-Mart Stores (WMT) latest expansion of its generic drug program represents more of the same despite the company's promise on Friday to make a “major health care announcement.” Nonetheless, the company’s latest comments shed additional light on the true economics of the program. Here are some high...

Pfizer attempts to leverage their original purchase by a sale of assets and retention of portions of the Esperion assets.  They appear to be retaining a portion of the research of the company while divesting the remaining technology.  They are keeping a small equity position in Esperion...

For decades, the Holy Grail for those pushing electronic health information technologies has been the ability to produce for physicians and other caregivers at the point of care complete information about patients from all sources to facilitate intelligent decision making. ...

In this publications there is am implication that the FDA will approve things faster as the FDA will after hiring so many people with fancy science backgrounds.  This might be true but it probably won't be the case.

The Heparin contamination has pushed the security of America’s pharmaceutical supply chain to the forefront of the news. I’m not yet sure how politician’s newfound involvement in the topic will play out. America needs to harmonize its own internal standards for the pharmaceutical supply chain, but politicians’...

There are some new developments for Average Manufacturer Price (AMP), although the situation has now devolved into a somewhat arcane legal battle. Unless there is a legislative fix (unlikely), then I expect that Center for Medicare and Medicaid Services (CMS) will punt this issue to the next administration...